Ben Gil Price, Director at Sarepta Therapeutics, holds 15.00K shares in Opus Genetics (Ticker: IRD), holds 37.33K shares in Sarepta Therapeutics (Ticker: SRPT), holds ― shares in MetaVia (Ticker: MTVA). Most recently, Ben Gil Price Bought ― shares of Opus Genetics on Jan 31, 2019 for an estimated value of 9.00K.
What is the percentage of profitable transactions made by Ben Gil Price?
The percentage of profitable transactions made by Ben Gil Price is 50%.
What is the average return per transaction made by Ben Gil Price?
The average return per transaction made by Ben Gil Price is 17.50%.
What stocks does Ben Gil Price hold?
Ben Gil Price holds: SRPT, IRD, MTVA stocks.
What was Ben Gil Price’s latest transaction?
Ben Gil Price latest transaction was an Informative Buy of $9.00K.
What was Ben Gil Price's most profitable transaction?
Ben Gil Price’s most profitable transaction was an Informative Buy of SRPT stock on March 16, 2016. The return on the trade was 108.50%.
What is Ben Gil Price's role in Sarepta Therapeutics?
Ben Gil Price's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.